Interactive animation from the CME Outfitters symposium: “Visualizing the Future: Advances in IL-23-Targeted Therapies in the Treatment of IBD.”
This activity is supported by an educational grant from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.- both are Johnson & Johnson companies.